" The world's leading malaria vaccine candidate appears to be a disappointment, with final study results showing it doesn't work very well and that initial protection fades over time. Despite the dismal results " it protects about one-third of children vaccinated " developers are moving ahead to get it approved because it could still help protect some children from getting the mosquito-spread disease.